Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2015-02-19 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a 'Year-end report' covering the period from 1 January to 31 December 2014. It contains comprehensive financial statements, including income statements, cash flow data, balance sheet information, and management commentary on business performance and outlook. It is not a short announcement or a certification, but a substantive financial report for a period shorter than a full fiscal year (in the context of a year-end report, it serves as the final quarterly/interim report for the fiscal year). Therefore, it is classified as an Interim/Quarterly Report. FY 2014
2015-02-19 English
Elos Medtech to enlarge plant in Skara
Regulatory Filings Classification · 95% confidence The document is explicitly titled "Press release" and announces a specific business event: Elos Medtech expanding its plant due to increased demand. It details operational changes, quotes management, and provides contact information for further inquiries. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it is a general announcement of a business development that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), it falls best under the general regulatory announcement category, which is RNS, as it is a public disclosure made under securities law obligations.
2015-01-20 English
Elos Medtech bygger ut fabriken i Skara
Regulatory Filings Classification · 99% confidence The document is explicitly titled "Pressrelease" and announces a specific business event: the expansion of a factory due to increased demand for molded plastic parts for medical technology customers. It details investment plans, quotes the CEO, and provides contact information, concluding with a statement that the information is being made public according to securities market laws. This structure strongly indicates a general corporate announcement or press release regarding operational/business developments, rather than a formal financial filing like a 10-K, Earnings Release (ER), or Interim Report (IR). Since there is no specific category for general operational press releases, and it is not a report announcement (RPA) but the announcement itself, the most appropriate fallback category is Regulatory Filings (RNS), as it is a mandatory public disclosure under Swedish law mentioned at the end.
2015-01-20 Swedish
Elos valberedning utsedd inför årsstämman 2015
Governance Information Classification · 95% confidence The document is a press release announcing the composition of the Nomination Committee (Valberedning) for the upcoming Annual General Meeting (Årsstämman) in 2015. It details the appointed members, the process for their appointment based on shareholder size, and the items the committee will propose to the AGM (e.g., election of board members, auditors, and remuneration). This content directly relates to the governance structure and the preparation for the AGM, specifically concerning board and management appointments, which falls under Board/Management Information (MANG) or Governance Information (CGR). However, the core subject is the *appointment* of the committee responsible for nominating directors and auditors, which is a key aspect of corporate governance structure and board composition. Given the specific definitions, MANG covers 'Announcement of changes in the company's board of directors or senior management.' While this is about the committee *selecting* the board, it is closely related to board composition. CGR covers 'Report detailing the company's internal rules, board structure, and governance practices.' Since this is an announcement about the structure of the body responsible for board nominations, CGR is a strong fit. However, the document also explicitly mentions the AGM date and the items to be proposed, which often accompanies AGM-related materials. Since the primary focus is the composition of the body that handles director nominations, MANG (Board/Management Information) or CGR (Governance Information) are the best fits. Given the focus on the *composition* of the nominating body, CGR (Governance Information) is slightly more precise than MANG, which usually implies changes to existing management/board members. I will classify it as CGR as it details a key component of the board structure process.
2014-10-27 Swedish
Elos Nomination Committee appointed ahead of Annual General Meeting 2015
AGM Information Classification · 98% confidence The document is a press release announcing the appointment of the Nomination Committee members ahead of the upcoming Annual General Meeting (AGM) scheduled for April 27, 2015. It details the composition rules for the committee, lists the appointed members, and outlines the issues the committee will propose to the 2015 AGM (election of Chairman, Board members, auditors, and remuneration). Since the core subject is the preparation and composition related to the AGM, specifically concerning the Nomination Committee which proposes board and auditor elections, this falls under the scope of AGM-related materials, even though it is an announcement rather than the final meeting presentation itself. It is not a general regulatory filing (RNS) because it is highly specific to the AGM process. It is not a DEF 14A (Remuneration) as it only mentions proposals for remuneration, not the final detailed report.
2014-10-27 English
Elos utnämner Johannes Lind-Widestam till ny VD och koncernchef från den 1 februari 2015
Board/Management Information Classification · 99% confidence The document is explicitly titled 'Pressrelease' and announces a significant change in senior leadership: the current CEO (VD) is stepping down, and a new CEO is being appointed, effective February 1, 2015. This directly matches the definition for Board/Management Information (MANG), which covers announcements of changes in senior management.
2014-10-24 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.